PeerVoice Heart & Lung Audio-logo

PeerVoice Heart & Lung Audio

Education Podcasts

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Location:

United States

Description:

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Language:

English


Episodes

Shifting the Treatment Paradigm in Type 2 Diabetes and CKD: The Role of Nonsteroidal MRAs

10/21/2021
Shifting the Treatment Paradigm in Type 2 Diabetes and CKD: The Role of Nonsteroidal MRAs

Duration:00:09:15

Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors

10/19/2021
Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors

Duration:00:12:53

Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors

8/11/2021
Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors

Duration:00:12:47

ASCVD: Reducing the Struggle of Keeping LDL-C at Recommended Levels

8/2/2021
ASCVD: Reducing the Struggle of Keeping LDL-C at Recommended Levels

Duration:00:25:23

Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights From 2021 Virtual Congresses

7/15/2021
Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights From 2021 Virtual Congresses

Duration:00:08:51

Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors

6/29/2021
Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors

Duration:00:10:44

Evaluating the Evidence for Managing CKD: Highlights From World Congress of Nephrology 2021

6/23/2021
Evaluating the Evidence for Managing CKD: Highlights From World Congress of Nephrology 2021

Duration:00:08:43

Checking In on Checkpoint Inhibitors: Current and Emerging Strategies for High PD-L1–Expressing Tumours in Advanced NSCLC

6/16/2021
Checking In on Checkpoint Inhibitors: Current and Emerging Strategies for High PD-L1–Expressing Tumours in Advanced NSCLC

Duration:00:29:23

"Improving Outcomes in Early-Stage EGFR-Mutant NSCLC: What Pathologists Can Do"

6/11/2021
"Improving Outcomes in Early-Stage EGFR-Mutant NSCLC: What Pathologists Can Do"

Duration:00:13:18

Reassessing What’s Possible in Early-Stage EGFR-mutant NSCLC: Insights from the Latest Data

6/9/2021
Reassessing What’s Possible in Early-Stage EGFR-mutant NSCLC: Insights from the Latest Data

Duration:00:40:44

Best Practices in Early-Stage EGFR-Mutant NSCLC: What Surgeons Need to Know

5/27/2021
Best Practices in Early-Stage EGFR-Mutant NSCLC: What Surgeons Need to Know

Duration:00:29:15

Evolving Treatment Paradigm in Early-Stage EGFR-Mutant NSCLC: A Primer for Medical Oncologists

5/11/2021
Evolving Treatment Paradigm in Early-Stage EGFR-Mutant NSCLC: A Primer for Medical Oncologists

Duration:00:16:20

Best Practices in Early-Stage EGFR-Mutant NSCLC: A Primer for Radiation Oncologists

5/10/2021
Best Practices in Early-Stage EGFR-Mutant NSCLC: A Primer for Radiation Oncologists

Duration:00:18:47

Improving Outcomes in Localised EGFR-Mutant NSCLC: Perspectives for Pulmonologists

5/7/2021
Improving Outcomes in Localised EGFR-Mutant NSCLC: Perspectives for Pulmonologists

Duration:00:26:23

"Setting New Goals for Slowing Progression in Chronic Kidney Disease: What Is Possible With GLP-1 RAs?"

5/3/2021
"Setting New Goals for Slowing Progression in Chronic Kidney Disease: What Is Possible With GLP-1 RAs?"

Duration:00:39:03

Understanding Hypercapnia in Adult Respiratory Distress Syndrome: The Quest for Optimal Patient Outcomes

3/12/2021
Understanding Hypercapnia in Adult Respiratory Distress Syndrome: The Quest for Optimal Patient Outcomes

Duration:00:12:54

GnRH Antagonist vs LHRH Agonist: To Desensitize or To Inhibit, That Is the Question!

2/17/2021
GnRH Antagonist vs LHRH Agonist: To Desensitize or To Inhibit, That Is the Question!

Duration:00:19:13

Stroke Prevention, Type 2 Diabetes, and GLP-1 Receptor Agonists: What Neurologists Need to Know

2/3/2021
Stroke Prevention, Type 2 Diabetes, and GLP-1 Receptor Agonists: What Neurologists Need to Know

Duration:00:44:47

Modern Management of Chronic Kidney Disease: A Look to the Future

1/20/2021
Modern Management of Chronic Kidney Disease: A Look to the Future

Duration:00:10:32

Cardiovascular Risk and Prostate Cancer: Clinical Perspectives on ADT

1/15/2021
Cardiovascular Risk and Prostate Cancer: Clinical Perspectives on ADT

Duration:00:22:24